| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.092 | 0.005 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |